Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 2961 - 2968 of 12144 results
OPT Class Action Settlement Will Help US Retain Talent
September 21, 2021| News
Monthly TCPA Digest — September 2021
September 21, 2021| Article| Viewpoint
TCPA Regulatory Update — FCC Attempts to Curb Robocalls to 911 Call Centers; Stop Illegal Robocalls from Entering American Phone Networks
September 21, 2021| Article| Viewpoint
TCPA Litigation Update — Sixth Circuit Holds TCPA Claims Arising Between November 2015 and July 2020 Are Viable
September 21, 2021| Article| Viewpoint
Levelling the Playing Field in ITC Patent Cases by Identifying Redesigns to a Set Deadline
September 21, 2021| News
When It Isn’t Better Late Than Never: ALJ Reins in on Redesigns First Disclosed in the Last Week of Fact Discovery
September 21, 2021| Blog| Viewpoint
USCIS Announces New COVID-19 Vaccination Requirement for Immigration Medical Examinations
September 20, 2021| Alert| Viewpoint
OIG Issues Favorable Advisory Opinion on Hospital’s Warranty Program for Joint Replacement Procedures
September 20, 2021| Blog| Viewpoint
News & Press Releases
Mintz Advises Point72 and Tsunami Express Car Wash in Acquisition of 53 Car Wash Locations from Whistle Express Car Wash
September 16, 2025
Mintz advised Point72 and Tsunami Express Car Wash, its portfolio company, in Tsunami’s acquisition of 53 car wash locations from Whistle Express Car Wash, which is owned by affiliates of Oaktree Capital Management.
Mintz Advises Charlesbank Capital Partners on Acquisition of Q6 Cyber
September 15, 2025
Mintz Advises on LB Pharmaceuticals’ $285 Million Initial Public Offering
September 12, 2025
Mintz advised the underwriters in connection with a $285 million initial public offering by LB Pharmaceuticals Inc of 19,000,000 shares of common stock at an initial public offering price of $15.00 per share. The aggregate gross proceeds to LB Pharmaceuticals from this offering were approximately $285 million before deducting underwriting discounts and commissions and other offering expenses. In addition, LB Pharmaceuticals granted the underwriters a 30-day option to purchase up to an additional 2,850,000 shares of common stock at the initial public offering price, less underwriting discounts and commissions. The shares began trading on the Nasdaq Global Market on September 11, 2025 under the ticker symbol “LBRX.”
Events
Podcasts
Mintz On Air: Practical Policies – DEI Developments: The Proxy Problem
September 16, 2025| Podcast|
Mintz On Air: Practical Policies – Disparage Me Not
August 26, 2025| Podcast|
Mintz On Air: Practical Policies - Investigations Unscripted
August 12, 2025| Podcast|